276 related articles for article (PubMed ID: 10820524)
21. Re: Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Lynge E; Rebolj M
J Natl Cancer Inst; 2010 May; 102(10):739; author reply 739-40. PubMed ID: 20360534
[No Abstract] [Full Text] [Related]
22. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus DNA testing in community screening for diseases of the cervix uteri.
Chan SY
Clin Sci (Lond); 1996 Sep; 91(3):250-2. PubMed ID: 8869401
[No Abstract] [Full Text] [Related]
24. Cervical cytology screening and management of abnormal cytology in adolescent girls.
Kahn JA; Hillard PJ; ; ;
J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):167-71. PubMed ID: 12804942
[No Abstract] [Full Text] [Related]
25. HPV testing for cervical neoplasia.
Carozzi F; Confortini M; Cecchini S; Ciatto S
Acta Cytol; 2001; 45(4):659-61. PubMed ID: 11480738
[No Abstract] [Full Text] [Related]
26. [HPV testing--weak justification for controversial decision].
Sønbø Kristiansen I
Tidsskr Nor Laegeforen; 2012 Jun; 132(12-13):1476-8. PubMed ID: 22766824
[No Abstract] [Full Text] [Related]
27. Primary HPV screening for cervical cancer.
Bhatla N; Singhal S
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():98-108. PubMed ID: 32291178
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
29. Screening for cervical cancer.
CA Cancer J Clin; 2020 Sep; 70(5):347-348. PubMed ID: 33460047
[No Abstract] [Full Text] [Related]
30. Menstrual pad, a cervical cancer screening tool, a population-based study in rural India.
Budukh A; Palayekar V; Maheshwari A; Deodhar K; Purwar P; Bagal S; Vadigoppula A; Lokhande M; Panse N; Dikshit R; Badwe R
Eur J Cancer Prev; 2018 Nov; 27(6):546-552. PubMed ID: 28704213
[TBL] [Abstract][Full Text] [Related]
31. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
32. The 2001 ASCCP management guidelines for cervical cytology.
Ferris DG
Am Fam Physician; 2004 Nov; 70(10):1866, 1868. PubMed ID: 15571055
[No Abstract] [Full Text] [Related]
33. ASC-US and HPV testing.
Choma KK
Am J Nurs; 2003 Feb; 103(2):42-50; 51 quiz. PubMed ID: 12582337
[No Abstract] [Full Text] [Related]
34. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
35. [Methods of cervical cancer screening and facing new problems in China].
Zhang WH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
[No Abstract] [Full Text] [Related]
36. Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice.
Armah H; Austin RM; Dabbs D; Zhao C
Arch Pathol Lab Med; 2009 Sep; 133(9):1426-30. PubMed ID: 19722749
[TBL] [Abstract][Full Text] [Related]
37. Is there a role for human papillomavirus testing in clinical practice?
Kaufman RH
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):724-5. PubMed ID: 11704159
[No Abstract] [Full Text] [Related]
38. Human papillomavirus testing for primary cervical cancer screening.
Cuzick J
JAMA; 2000 Jan; 283(1):108-9. PubMed ID: 10632290
[No Abstract] [Full Text] [Related]
39. HPV DNA testing in cervical cancer screening: from evidence to policies.
Cox T; Cuzick J
Gynecol Oncol; 2006 Oct; 103(1):8-11. PubMed ID: 16919716
[No Abstract] [Full Text] [Related]
40. [Impact of HPV testing on cervical cancer screening].
Li G
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):241-5. PubMed ID: 26080933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
